Loading clinical trials...
Loading clinical trials...
Coral is conducting a large study comparing and predicting the relative effectiveness of different medications for autoimmune patients. Patients with Inflammatory Bowel Disease (IBD) who have been di...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Coral Genomics, Inc.
Collaborators
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06180382 · Crohn's Disease
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07550673 · Acute Severe Ulcerative Colitis
NCT07474792 · Plaque Psoriasis
Coral Genomics, Inc.
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions